أعرض في EDS

Pharmacokinetics and Effect on Type 2 Biomarker Levels of Dupilumab Weight Tiered-Based Dose Regimens in Patients Aged 6 to 11 Years with Uncontrolled, Moderate-to-Severe Asthma

التفاصيل البيبلوغرافية
العنوان:	Pharmacokinetics and Effect on Type 2 Biomarker Levels of Dupilumab Weight Tiered-Based Dose Regimens in Patients Aged 6 to 11 Years with Uncontrolled, Moderate-to-Severe Asthma
المؤلفون:	D.J. Jackson, L.B. Bacharier, L. Sher, C. Domingo Ribas, N. Papadopoulos, B.D. Modena, N. Li, C. Xia, S. Harel, K. Wolfe, M. Kamal, R. Gall, N. Amin, L. Mannent, E. Laws, P.J. Rowe, J.A. Jacob-Nara, Y. Deniz, D.J. Lederer, M.E. Hardin, C. Xu
المصدر:	C101. EXPANDING THE USE OF ASTHMA BIOLOGICS AND OTHER NOVEL THERAPEUTICS TO ADDITIONAL PATIENT POPULATIONS.
بيانات النشر:	American Thoracic Society, 2022.
سنة النشر:	2022
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=doi_________::f2f237e6e4b5e4b4bcd9db26328f2ca3Test https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4846Test
رقم الانضمام:	edsair.doi...........f2f237e6e4b5e4b4bcd9db26328f2ca3
قاعدة البيانات:	OpenAIRE

الوصف
الوصف غير متاح.